Pancreatic cancer tumor classification could optimize treatment choices

November 22, 2019

A study from the University of North Carolina Lineberger Comprehensive Cancer Center could help predict resistance to treatments for pancreatic cancer, one of the deadliest cancer types. In the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, researchers led by UNC Lineberger’s Jen Jen Yeh, MD, and Naim Rashid, PhD, reported … Continued

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

December 17, 2017

Richard Moffitt, a post-doctoral fellow in our group and now a tenure-track assistant professor at SUNY Stonybrook, led the mRNA and integrative analysis for the TCGA PAAD (pancreatic cancer) working group. The TCGA PAAD team performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic ductal adenocarcinoma specimens, including samples with characteristic low neoplastic cellularity. … Continued